ICON: ICLR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ICON PLC Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of ICON PLC (NASDAQ:ICLR) ordinary shares between July 27, 2023 and October 23, 2024, both dates inclusive (the "Class Period"), have until Friday, April 11, 2025 to seek appointment as lead plaintiff of the ICON class action lawsuit. Captioned Shing v. ICON plc, No. 25-cv-00763 (E.D.N.Y.), the ICON class action lawsuit charges ICON as well as certain of ICON's top executive officers with violations of the Securities Exchange Act of 1934.If you suffered substantial losses and wish to serve as lead plaintiff of the ICON class action lawsuit, please provide your information here:https://www.rgrdlaw.com/cases-icon-plc-class-action-lawsuit-iclr.htmlYou can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at info@rgrdlaw.com.CASE ALLEGATIONS: ICON is a clinical research organization ("CRO").The ICON class action lawsuit alleges that defendants throughout the Class period made false and/or misleading statements and/or failed to disclose that: (i) ICON was suffering from a material loss of business due to customer cost reduction measures and other widespread funding limitations impacting ICON's client base; (ii) ICON's purported Functional Service Provision ("FSP") and hybrid model offerings were insufficient to shield ICON from the adverse effects of a significant market downturn; (iii) the requests for proposals ICON received from its biotechnology customers during the Class Period were used in substantial part as price discovery tools, and thus ...Full story available on Benzinga.com